Insu Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $220K

  • Investors
  • 2

Insu Therapeutics General Information

Description

Developer of a buccal drug delivery platform designed to transform injectable peptide medications into oral tablets. The company's platform utilizes mucoadhesive tablets and a mucosal absorption technology to deliver insulin and glucagon-like peptide-1 medications through the oral cavity, bypassing the gastrointestinal tract and liver metabolism issues, enabling diabetic patients to manage chronic conditions without needle injections, refrigeration requirements, or gastrointestinal degradation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Vancouver, British Columbia
  • Canada
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Corporate Office
  • Vancouver, British Columbia
  • Canada

Insu Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Insu Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 06-Mar-2026 $220K Completed Generating Revenue
2. Later Stage VC 01-Jan-2024 Completed Generating Revenue
1. University Spin-Out 19-Oct-2018 Completed Startup
To view Insu Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Insu Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Victory Square Technologies Venture Capital Minority
The University of British Columbia University
To view Insu Therapeutics’s complete investors history, request access »

Insu Therapeutics FAQs

  • When was Insu Therapeutics founded?

    Insu Therapeutics was founded in 2018.

  • Where is Insu Therapeutics headquartered?

    Insu Therapeutics is headquartered in Vancouver, Canada.

  • What industry is Insu Therapeutics in?

    Insu Therapeutics’s primary industry is Drug Delivery.

  • Is Insu Therapeutics a private or public company?

    Insu Therapeutics is a Private company.

  • What is Insu Therapeutics’s current revenue?

    The current revenue for Insu Therapeutics is .

  • How much funding has Insu Therapeutics raised over time?

    Insu Therapeutics has raised $220K.

  • Who are Insu Therapeutics’s investors?

    Victory Square Technologies and The University of British Columbia have invested in Insu Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process